PLX position history
The shares of Protalix Biotherapeutics (PLX) that Opaleye Management Inc. reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q3: 2,580,556 shares, $5.7M, 0.81% of portfolio, New
- 2025 Q4: 4,956,352 shares, $8.9M, 1.2% of portfolio, Add +92.1%
- 2026 Q1: 340,000 shares, $738K, 0.10% of portfolio, Reduce −93.1%
- 2026 Q2: not held, Exit
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|